Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1002935 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19468447 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL118217 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19468521 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19946200 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19946211 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19468478 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL238797 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19946206 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19468520 | 1.00 | DNM1 (0.50) | DNM1CA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-26 | — | — | US | claimed |
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | claimed |
| CN-105001154-A | Method for synthesizing 2-halogenated nicotinate and intermediate thereof through ionic liquid method | UNIV SHANDONG NORMAL | 2015-10-28 | — | — | CN | claimed |
| CN-104945317-A | Method for synthesizing 2-halogenated ester nicotinate and 2-halogenated ester nicotinate intermediate according to ultrasonic method | UNIV SHANDONG NORMAL | 2015-09-30 | — | — | CN | claimed |
| CN-104945316-A | Method for synthesizing 2-halogenated nicotinic acid ester and intermediates thereof through microwave method | UNIV SHANDONG NORMAL | 2015-09-30 | — | — | CN | claimed |
| US-5773658-A | REACTING AN ALDEHYDE WITH A PRIMARY AMINE TO FORM SCHIFF BASE; THEN WITH METHYLAMINE AND HYDROGEN IN PRESENCE OF A HYDROGENATION CATALYST | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-30 | — | — | US | claimed |
| EP-0484790-B1 | Process for the preparation of N-methyl-alkylamines | HOECHST AG (DE) | 1994-09-14 | — | — | EP | claimed |
| US-4996316-A | Catalytic reacting a primart amine with formaldehyde and hydrogen | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-02-26 | — | — | US | claimed |
| US-4473491-A | Alkanolamine salts of cyclic amide acids and their use as metal corrosion inhibitors in aqueous systems | BASF AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | claimed |
| US-12553176-B2 | Treatment agent for carbon fiber precursor, composition containing treatment agent for carbon fiber precursor, and carbon fiber precursor | TAKEMOTO OIL & FAT CO., LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20240328071-A1 | TREATMENT AGENT FOR CARBON FIBER PRECURSOR, COMPOSITION CONTAINING TREATMENT AGENT FOR CARBON FIBER PRECURSOR, AND CARBON FIBER PRECURSOR | TAKEMOTO OIL & FAT CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-118715349-A | Treatment agent for carbon fiber precursor, composition containing treatment agent for carbon fiber precursor, and carbon fiber precursor | 竹本油脂株式会社 | 2024-09-27 | — | — | CN | disclosed |
| WO-2024140595-A1 | TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2024-07-04 | — | — | WO | disclosed |
| CN-107209146-B | Electrochemical gas sensor and electrolyte for electrochemical gas sensor | 德尔格安全股份两合公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-0323573-A2 | Process for the preparation of tertiary N,N-dimethyl amines | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-12 | — | — | EP | disclosed |
| EP-0186083-A2 | N-(2-Hyxdroxyalkyl)-amino acids and their derivatives, process for their preparation and pharmaceutical compositions containing them | ASTA Pharma AG (DE) | 1986-07-02 | — | — | EP | disclosed |
| US-4473491-A | Alkanolamine salts of cyclic amide acids and their use as metal corrosion inhibitors in aqueous systems | BASF AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | disclosed |
| US-4207285-A | LOW-FOAM | BASF AKTIENGESELLSCHAFT (DE) | 1980-06-10 | — | — | US | disclosed |
| US-4154779-A | HIGH PRESSURE LUBRICANT ADDITIVE, CORROSION RESISTANT; SULFURIZATION, PHOSPHORIZATION, NEUTRALIZATION | RHEIN-CHEMIE RHEINAU GMBH (DE) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | DOT1L, EHMT2, CDH1 | DNM1 4319/4885CA12 650/4885CA1 614/4885 |
| US-12553176-B2 | Treatment agent for carbon fiber precursor, composition containing treatment agent for carbon fiber precursor, and carbon fiber precursor | FLNA, EMD, WDR82 | DNM1 2624/4885CA12 1184/4885CA1 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.